Skip to main content

Multifunctional dyes as smart applied molecular bioprobes

FJC2021-046650-I

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprogram Subprograma Estatal de Formación
Call Juan de la Cierva Formación
Call year 2021
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DEL PAIS VASCO EUSKAL HERRIKO UNIBERTSITATEA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT

  • Garcia Sampedro, Andrés
  • Prieto Castañeda, Alejandro
  • Rodríguez Agarrabeitia, Antonia
  • Bañuelos Prieto, Jorge
  • García Moreno, Inmaculada
  • Villanueva Oroquieta, Ángeles
  • Moya Cerero, Santiago de la
  • Ortiz García, María Josefa
  • Acedo Núñez, Pilar
The potential of using image-guided photodynamic therapy (ig-PDT) for cancer, especially with highly biocompatible fluorescent agents free of heavy atoms, is well recognized. This is due to key advantages related to minimizing adverse side effects associated with standard cancer chemotherapy. However, this theragnostic approach is strongly limited by the lack of synthetically-accessible and easily-modulable chemical scaffolds, enabling the rapid design and construction of advanced agents for clinical ig-PDT. In fact, there are still very few ig-PDT agents clinically approved. Herein we report a readily accessible, easy-tunable and highly fluorescent all-organic small photosensitizer, as a model design for accelerating the development and translation of advanced ig-PDT agents for cancer. This scaffold is based on BODIPY, which assures high fluorescence, accessibility, and ease of performance adaptation by workable chemistry. The optimal PDT performance of this BODIPY dye, tested in highly resistant pancreatic cancer cells, despite its high fluorescent behavior, maintained even after fixation and cancer cell death, is based on its selective accumulation in mitochondria. This induces apoptosis upon illumination, as evidenced by proteomic studies and flow cytometry. All these characteristics make the reported BODIPY-based fluorescent photosensitizer a valuable model for the rapid development of ig-PDT agents for clinical use.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A highly fluorescent and readily accessible all-organic photosensitizer model for advancing image-guided cancer PDT

  • Garcia-Sampedro, Andres
  • Prieto-Castañeda, Alejandro
  • Agarrabeitia, Antonia R.
  • Bañuelos, Jorge
  • García-Moreno, I.
  • Villanueva, Angeles
  • Moya, Santiago de la
  • Ortiz, María J.
  • Acedo, Pilar
8 pags., 4 figs., The potential of using image-guided photodynamic therapy (ig-PDT) for cancer, especially with highly biocompatible fluorescent agents free of heavy atoms, is well recognized. This is due to key advantages related to minimizing adverse side effects associated with standard cancer chemotherapy. However, this theragnostic approach is strongly limited by the lack of synthetically-accessible and easily-modulable chemical scaffolds, enabling the rapid design and construction of advanced agents for clinical ig-PDT. In fact, there are still very few ig-PDT agents clinically approved. Herein we report a readily accessible, easy-tunable and highly fluorescent all-organic small photosensitizer, as a model design for accelerating the development and translation of advanced ig-PDT agents for cancer. This scaffold is based on BODIPY, which assures high fluorescence, accessibility, and ease of performance adaptation by workable chemistry. The optimal PDT performance of this BODIPY dye, tested in highly resistant pancreatic cancer cells, despite its high fluorescent behavior, maintained even after fixation and cancer cell death, is based on its selective accumulation in mitochondria. This induces apoptosis upon illumination, as evidenced by proteomic studies and flow cytometry. All these characteristics make the reported BODIPY-based fluorescent photosensitizer a valuable model for the rapid development of ig-PDT agents for clinical use., Authors acknowledge grants PID2020-114755GB-C31,-C32 and-C33 funded by Spanish MCIN/AEI/10.13039/501100011033, and grant IT1639-22 funded by Basque Government. A. P.-C. thanks grant FJC2021-046650-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. P. A. thanks funding from Pancreatic Cancer UK and the Ramon Areces Foundation., Peer reviewed